뒤로
Ascletis Pharma Inc(01672.HK) 가격
01672.HK 주가 차트
ASCLETIS-B (01672.HK)
Ascletis Pharma Inc
HK$16.6
0.66%
$0.11
장 종료: Feb 16, 12:00:00 HKT
주요 통계
이전 종가
$16.42
시가
$16.49
일일 범위
$15.8 - $16.8
52주 범위
$2.82 - $18.75
거래량
--
평균 거래량
5.9M
EPS(TTM)
-0.29
배당수익률
--
시가총액
$16.3B
ASCLETIS-B란 무엇인가요?
Ascletis Pharma, Inc. engages in the research and development, production, marketing, and sale of pharmaceutical products. The company is headquartered in Hangzhou, Zhejiang and currently employs 208 full-time employees. The company went IPO on 2018-08-01. The firm focuses on viral diseases, non-alcoholic steatohepatitis (NASH) or primary biliary cholangitis (PBC), and oncology. The firm's product pipeline includes ASC22 for chronic hepatitis B functional cure, ASC10 for respiratory syncytial virus (RSV), ASC22 for human immunodeficiency virus (HIV) functional cure, ASC10 and ASC11 for COVID-19, ASC41 for NASH, ASC42 for PBC, ASC61 for solid tumors, ASC40 for moderate and severe acne, and others. The firm conducts its business in the domestic and overseas markets.